Hajri Rami, Ponti Alexandre, Meuwly Jean-Yves, Eminian Sylvain, Ledoux Jean-Baptiste, Tenisch Estelle, Alamo-Maestre Leonor, Dromain Clarisse, Violi Naïk Vietti
Department of Radiology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland.
Centre for Biomedical Imaging (CIBM), Lausanne, Switzerland.
J Cancer Sci Clin Ther. 2022;6(4):452-459. doi: 10.26502/jcsct.5079184. Epub 2022 Dec 21.
The aim of this study was to assess the diagnostic performance of abbreviated MRI (AMRI) using the maximal intensity projection (MIP) reconstruction of the first post-contrast acquisition subtracted (FAST) compared with MIP+FAST and full-protocol MRI (fpMRI) for the preoperative assessment of breast cancer (BC) in a biopsy-proven cancer population.
In this monocentric retrospective study, two readers consensually assessed two AMRI protocols consisting of MIP reconstruction of the FAST (MIP) and MIP+FAST. 228 patients were included with a breast MRI performed between 2013 and 2014, 207 of them (90.8%) had biopsy-proven cancer with 256 lesions. Data of MIP and MIP+FAST were compared to full-protocol MRI (fpMRI) reading and to the reference standard including 6-month follow-up imaging and pathology as the reference.
MIP, MIP+FAST and fpMRI demonstrated a per-lesion sensitivity for BC detection of 87.5% (224/256, 95%CI: 82.9-91.3%) and 97.7% (250/256, 95-99.1%) and 98.4% (252/256, 96.1-99.6%), respectively with a statistical difference between MIP compared to MIP+FAST and fpMRI when considering confidence intervals. Per-lesion specificity was not different [MIP: 47.6% (10/21, 25.7-70.2%), MIP+FAST: 52.4% (11/21,29.8-74.3%, fpMRI: 66.7% (14/21, 43-85.4%)].
AMRI using only MIP is not accurate for the pre-operative assessment of BC due to lower sensitivity when compared to MIP+FAST and fpMRI. AMRI using the MIP+FAST acquisition in the preoperative setting seems promising as it could be used as the same protocol for both screening and staging in case of positive cases, without need for a recall fpMRI. This needs confirmation with cohort including higher rate of negative cases in order to evaluate the specificity.
本研究旨在评估在经活检证实患有癌症的人群中,使用首次增强后采集的最大强度投影(MIP)重建减影(FAST)的简化MRI(AMRI)与MIP+FAST及全协议MRI(fpMRI)相比,对乳腺癌(BC)进行术前评估的诊断性能。
在这项单中心回顾性研究中,两名阅片者一致评估了两种AMRI方案,即FAST的MIP重建(MIP)和MIP+FAST。纳入了228例在2013年至2014年间进行乳腺MRI检查的患者,其中207例(90.8%)经活检证实患有癌症,共256个病灶。将MIP和MIP+FAST的数据与全协议MRI(fpMRI)阅片结果以及包括6个月随访成像和病理检查作为参考的参考标准进行比较。
MIP、MIP+FAST和fpMRI对BC检测的每病灶敏感性分别为87.5%(224/256,95%CI:82.9-91.3%)、97.7%(250/256,95-99.1%)和98.4%(252/256,96.1-99.6%),考虑置信区间时,MIP与MIP+FAST及fpMRI之间存在统计学差异。每病灶特异性无差异[MIP:47.6%(10/21,25.7-70.2%),MIP+FAST:52.4%(11/21,29.8-74.3%),fpMRI:66.7%(14/21,43-85.4%)]。
仅使用MIP的AMRI在BC术前评估中不准确,因为与MIP+FAST和fpMRI相比敏感性较低。术前使用MIP+FAST采集的AMRI似乎很有前景,因为在阳性病例中它可作为筛查和分期的相同方案,无需再次进行fpMRI检查。这需要在包括更高比例阴性病例的队列中得到证实,以评估其特异性。